About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MENDD Tolerance Assessment Study | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT06185088

MENDD Tolerance Assessment Study

This study will utilize approved devices in an off-label manner to create forces required to induce intestinal lengthening. Radial and longitudinal forces are both required, and two devices will be us...

Lead sponsor: University of Michigan•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Michigan

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Existing Ileostomy older than 6 weeks Undergoing any existing procedure in endoscopy suite or operating room.

Exclusion Criteria

•Inflammatory bowel disease of small bowel Pregnant Short bowel syndrome Bleeding disorder Chronic pain disorder Individuals taking chronic pain medications including prescriptions, cannabinoids or over the counter.
•Individuals taking pain medications at the time of the procedure Cognitive Impairment to the extent that the questionnaire cannot be completed

Related studies

RECRUITINGPhase 3

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

NCT07197944 · Short Bowel Syndrome

A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)

NCT05561647 · Short Bowel Syndrome (SBS)

RECRUITINGPhase 3

A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

NCT06973304 · Short Bowel Syndrome

Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

NCT06427642 · Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia, and more

Enrolling By InvitationNA

Palliative Care Needs of Children With Rare Diseases and Their Families

NCT06938542 · Trisomy 13 Syndrome, Arthrogryposis Congenita Multiplex With Intestinal Atresia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 3, 2024Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment1

Start dateMar 2023

Last updatedOct 3, 2024

Condition

Short Bowel Syndrome

Locations shown

Michigan Medicine

Ann Arbor, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions